Most are mild and temporary
Conversely, GA, CGA, and Q3G increased antiinflammatory cytokines, such as IL-10, IL-4, and IL-5 [20, 23, 33], indicating a balanced modulation of the inflammatory response
A product may demonstrate: Better stability in a laboratory Higher blood levels after a dose Increased glutathione in selected cells Changes in an oxidative-stress biomarker Those findings can be meaningful, but they do not automatically prove that the product: Improves energy or cognition Prevents cardiovascular or neurodegenerative disease Detoxifies the body in a clinically meaningful way Treats chronic illness Slows biological aging Improves longevity Those larger claims require controlled clinical trials measuring patient-important outcomes
Learn about Dysautonomia and POTS from Brit Adler, MD, Assistant Professor of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine